Dr. Bose is a Consultant in biologics process development and manufacturing. Services offered include: (1) Development/execution of clinical and commercial manufacturing strategies for both innovator biologics and biosimilars (especially, monoclonal antibody and recombinant protein therapeutics); (2) Evaluation of manufacturing localization options for emerging markets; (3) Input for Corporate Biotechnology Strategic Plans; (4) Technical due diligence and "Clean" Team representation for prospective mergers and acquisitions; and (5) Advice on CMC Regulatory Strategy and assistance with preparation for upcoming FDA Advisory Committee Meetings.Arindam's long career in the biopharmaceutical industry included positions of increasing responsibility in bioprocess development, clinical supply manufacturing, corporate biotechnology strategy and advocacy for science-based regulations for biologics, including biosimilars. Most recently, he served as Vice-President, External Affairs and Biosimilar Strategy for the Biotherapeutics Pharmaceutical Sciences organization of Pfizer Worldwide R&D. His group was responsible for biopharmaceutical product development outsourcing, competitive intelligence and external influencing in addition to developing and executing Pfizer’s entry strategy for biosimilars. He has led numerous technical due diligence teams for both product in-licensing and company acquisitions.